BrainScan

Country:
Poland
Founding year:
2016

BrainScan develops an AI radiology decision-support system for brain CT interpretation, positioned for use in emergency and neuroimaging workflows. The platform is offered as medical software intended to support clinical reading and triage.

The system applies a proprietary deep-learning model to head CT data, automatically detecting and classifying a set of common brain pathologies and highlighting suspected findings. Results are returned within existing imaging workflows via PACS and DICOM viewer integration, with options for cloud or on-premise deployment.

Primary use cases include faster prioritization of urgent cases such as hemorrhage, stroke-related findings, and intracranial injury in hospital radiology and emergency settings. BrainScan positions its product within regulated clinical deployment across multiple markets, targeting scalability across routine CT volumes.

Neuroimaging
Decision Support
Clinical Workflows

Neurofounders Insights

Modality:
Software
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Multi-indication
Target user:
Clinicians
Regulatory stage:
CE-Marked

Seed

BrainScan is positioned as a broad-spectrum AI brain CT analyzer detecting 30 pathologies from non-contrast scans, a wider diagnostic scope than most competitors that focus on single conditions like stroke or hemorrhage. With CE Class IIa marking and a hardware-agnostic SaaS delivery model, it targets integration into existing radiology workflows across European and UK hospital systems.

Related companies

Articles featuring

BrainScan

No articles yet!

Press releases

No press releases published yet.